REVIEW article
Front. Oncol.
Sec. Cancer Epidemiology and Prevention
Hepatitis B Virus, Alcohol, and Liver Cancer
Provisionally accepted
- Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Viral hepatitis is an infection caused by hepatotropic viruses that leads to liver inflammation and may progress from a prolonged asymptomatic phase to decompensated liver disease. Among the main types, hepatitis A (HAV), B (HBV), and C(HCV) are most common, with HBV being the most widespread worldwide. Both HBV and HCV contribute substantially to global morbidity and mortality. However, HBV accounts for the most significant burden of chronic infections and associated complications, including cirrhosis and hepatocellular carcinoma (HCC). HBV infection is one of the leading causes of HCC globally. The chronically infected individuals face a lifetime risk of up to 25% of developing liver cancer, which progresses from cirrhosis and is affected by many comorbidities. Clinical and epidemiological studies, including research from our group, have shown that alcohol consumption in HBV-infected people speeds up disease progression, increases viral replication, and worsens liver damage. Heavy alcohol use is a major cofactor that significantly raises the risk of HCC in patients with HBV-related cirrhosis. Despite this well-established link, the safe level of alcohol consumption for HBV-infected patients remains unclear. Additionally, other cofactors such as viral co-infections, metabolic disorders, genetic predisposition, demographic factors, and environmental exposures interact with alcohol to influence HBV-related disease outcomes. Understanding the systemic effects of alcohol and its underlying mechanisms in HBV development is essential to defining its role as a comorbid factor in liver disease progression. This brief review highlights current knowledge and mechanistic insights into how alcohol influences HBV infection, contributes to HCC development, and acts as a comorbid factor that worsens disease severity.
Keywords: alcohol, HBV, Hepatocellular Carcinoma, Immune dysregulation, liver inflammation, Risk factors, viral replication
Received: 21 Nov 2025; Accepted: 03 Feb 2026.
Copyright: © 2026 Pathania and Osna. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Anup Singh Pathania
Natalia A Osna
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.